Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Prickle1 regulates differentiation of frontal bone osteoblasts.

Wan Y, Lantz B, Cusack BJ, Szabo-Rogers HL.

Sci Rep. 2018 Dec 21;8(1):18021. doi: 10.1038/s41598-018-36742-0.

2.

Addition of Neostigmine and Atropine to Conventional Management of Postdural Puncture Headache: A Randomized Controlled Trial.

Abdelaal Ahmed Mahmoud A, Mansour AZ, Yassin HM, Hussein HA, Kamal AM, Elayashy M, Elemady MF, Elkady HW, Mahmoud HE, Cusack B, Hosny H, Abdelhaq M.

Anesth Analg. 2018 Dec;127(6):1434-1439. doi: 10.1213/ANE.0000000000003734.

PMID:
30169405
3.

Decarbamoylation of acetylcholinesterases is markedly slowed as carbamoyl groups increase in size.

Venkatasubban KS, Johnson JL, Thomas JL, Fauq A, Cusack B, Rosenberry TL.

Arch Biochem Biophys. 2018 Oct 1;655:67-74. doi: 10.1016/j.abb.2018.08.006. Epub 2018 Aug 9.

4.

Growth factor signaling alters the morphology of the zebrafish ethmoid plate.

Cusack BJ, Parsons TE, Weinberg SM, Vieira AR, Szabo-Rogers HL.

J Anat. 2017 May;230(5):701-709. doi: 10.1111/joa.12592. Epub 2017 Feb 28.

5.
6.

Accelerated enamel mineralization in Dspp mutant mice.

Verdelis K, Szabo-Rogers HL, Xu Y, Chong R, Kang R, Cusack BJ, Jani P, Boskey AL, Qin C, Beniash E.

Matrix Biol. 2016 May-Jul;52-54:246-259. doi: 10.1016/j.matbio.2016.01.003. Epub 2016 Jan 15.

7.

Physical activity and cognitive function in individuals over 60 years of age: a systematic review.

Carvalho A, Rea IM, Parimon T, Cusack BJ.

Clin Interv Aging. 2014 Apr 12;9:661-82. doi: 10.2147/CIA.S55520. eCollection 2014. Review.

8.

Predator and prey activity levels jointly influence the outcome of long-term foraging bouts.

Sweeney K, Cusack B, Armagost F, O'Brien T, Keiser CN, Pruitt JN.

Behav Ecol. 2013 Sep;24(5):1205-1210. Epub 2013 Jun 17.

9.

A mass spectrometric approach for characterization of amyloid-β aggregates and identification of their post-translational modifications.

Tay WM, Bryant JG, Martin PK, Nix AJ, Cusack BM, Rosenberry TL.

Biochemistry. 2012 May 8;51(18):3759-66. doi: 10.1021/bi300316d. Epub 2012 Apr 25.

PMID:
22506642
10.

Ureteric morphogenesis requires Fgfr1 and Fgfr2/Frs2α signaling in the metanephric mesenchyme.

Sims-Lucas S, Di Giovanni V, Schaefer C, Cusack B, Eswarakumar VP, Bates CM.

J Am Soc Nephrol. 2012 Apr;23(4):607-17. doi: 10.1681/ASN.2011020165. Epub 2012 Jan 26.

11.

Preventing dangerous nonsense: selection for robustness to transcriptional error in human genes.

Cusack BP, Arndt PF, Duret L, Roest Crollius H.

PLoS Genet. 2011 Oct;7(10):e1002276. doi: 10.1371/journal.pgen.1002276. Epub 2011 Oct 13.

12.

The coenzyme A disulphide reductase of Borrelia burgdorferi is important for rapid growth throughout the enzootic cycle and essential for infection of the mammalian host.

Eggers CH, Caimano MJ, Malizia RA, Kariu T, Cusack B, Desrosiers DC, Hazlett KR, Claiborne A, Pal U, Radolf JD.

Mol Microbiol. 2011 Nov;82(3):679-97. doi: 10.1111/j.1365-2958.2011.07845.x. Epub 2011 Oct 12.

13.

Independent roles of Fgfr2 and Frs2alpha in ureteric epithelium.

Sims-Lucas S, Cusack B, Eswarakumar VP, Zhang J, Wang F, Bates CM.

Development. 2011 Apr;138(7):1275-80. doi: 10.1242/dev.062158. Epub 2011 Feb 24.

14.

Fgfr1 and the IIIc isoform of Fgfr2 play critical roles in the metanephric mesenchyme mediating early inductive events in kidney development.

Sims-Lucas S, Cusack B, Baust J, Eswarakumar VP, Masatoshi H, Takeuchi A, Bates CM.

Dev Dyn. 2011 Jan;240(1):240-9. doi: 10.1002/dvdy.22501.

15.

Localized hypermutation and associated gene losses in legume chloroplast genomes.

Magee AM, Aspinall S, Rice DW, Cusack BP, Sémon M, Perry AS, Stefanović S, Milbourne D, Barth S, Palmer JD, Gray JC, Kavanagh TA, Wolfe KH.

Genome Res. 2010 Dec;20(12):1700-10. doi: 10.1101/gr.111955.110. Epub 2010 Oct 26. Erratum in: Genome Res. 2014 Jun;24(6):1052.

16.

Cholesterol lipids of Borrelia burgdorferi form lipid rafts and are required for the bactericidal activity of a complement-independent antibody.

LaRocca TJ, Crowley JT, Cusack BJ, Pathak P, Benach J, London E, Garcia-Monco JC, Benach JL.

Cell Host Microbe. 2010 Oct 21;8(4):331-42. doi: 10.1016/j.chom.2010.09.001.

17.

Rationally designed dehydroalanine (DeltaAla)-containing peptides inhibit amyloid-beta (Abeta) peptide aggregation.

Rangachari V, Davey ZS, Healy B, Moore BD, Sonoda LK, Cusack B, Maharvi GM, Fauq AH, Rosenberry TL.

Biopolymers. 2009 Jun;91(6):456-65. doi: 10.1002/bip.21151.

PMID:
19189374
18.

Proteomic profiling of phosphoproteins and glycoproteins responsive to wild-type alpha-synuclein accumulation and aggregation.

Kulathingal J, Ko LW, Cusack B, Yen SH.

Biochim Biophys Acta. 2009 Feb;1794(2):211-24. doi: 10.1016/j.bbapap.2008.09.025. Epub 2008 Oct 22.

19.

Analysis of the reaction of carbachol with acetylcholinesterase using thioflavin T as a coupled fluorescence reporter.

Rosenberry TL, Sonoda LK, Dekat SE, Cusack B, Johnson JL.

Biochemistry. 2008 Dec 9;47(49):13056-63. doi: 10.1021/bi8015197.

20.

Monitoring the reaction of carbachol with acetylcholinesterase by thioflavin T fluorescence and acetylthiocholine hydrolysis.

Rosenberry TL, Sonoda LK, Dekat SE, Cusack B, Johnson JL.

Chem Biol Interact. 2008 Sep 25;175(1-3):235-41. doi: 10.1016/j.cbi.2008.06.002. Epub 2008 Jun 17.

21.

Substrate-targeting gamma-secretase modulators.

Kukar TL, Ladd TB, Bann MA, Fraering PC, Narlawar R, Maharvi GM, Healy B, Chapman R, Welzel AT, Price RW, Moore B, Rangachari V, Cusack B, Eriksen J, Jansen-West K, Verbeeck C, Yager D, Eckman C, Ye W, Sagi S, Cottrell BA, Torpey J, Rosenberry TL, Fauq A, Wolfe MS, Schmidt B, Walsh DM, Koo EH, Golde TE.

Nature. 2008 Jun 12;453(7197):925-9. doi: 10.1038/nature07055.

22.

Bishops and religious institutes: building collaboration.

Cusack BA.

Health Prog. 2008 May-Jun;89(3):12-3. No abstract available.

PMID:
18488692
23.

How does the "communion of the church" apply to Catholic health care?

Cusack BA.

Health Prog. 2007 Sep-Oct;88(5):14-5. No abstract available.

PMID:
17896687
24.

When gene marriages don't work out: divorce by subfunctionalization.

Cusack BP, Wolfe KH.

Trends Genet. 2007 Jun;23(6):270-2. Epub 2007 Apr 5. Review.

PMID:
17418444
25.

Not born equal: increased rate asymmetry in relocated and retrotransposed rodent gene duplicates.

Cusack BP, Wolfe KH.

Mol Biol Evol. 2007 Mar;24(3):679-86. Epub 2006 Dec 18.

PMID:
17179139
26.

The role of the diocesan bishop in relation to Catholic health care.

Cusack BA.

Health Prog. 2006 Jul-Aug;87(4):64. No abstract available.

PMID:
16883732
27.

Prevention of chronic anthracycline cardiotoxicity in the adult Fischer 344 rat by dexrazoxane and effects on iron metabolism.

Cusack BJ, Gambliel H, Musser B, Hadjokas N, Shadle SE, Charlier H, Olson RD.

Cancer Chemother Pharmacol. 2006 Oct;58(4):517-26. Epub 2006 Mar 23.

PMID:
16555089
28.

Steric effects in the decarbamoylation of carbamoylated acetylcholinesterases.

Venkatasubban KS, Johnson JL, Thomas JL, Fauq A, Cusack B, Rosenberry TL.

Chem Biol Interact. 2005 Dec 15;157-158:433-4. No abstract available.

PMID:
16429582
29.

Measuring carbamoylation and decarbamoylation rate constants by continuous assay of AChE.

Johnson JL, Thomas JL, Emani S, Cusack B, Rosenberry TL.

Chem Biol Interact. 2005 Dec 15;157-158:384-5. No abstract available.

PMID:
16429515
30.

A novel strategy for protection against organophosphate toxicity: Evolution of cyclic inhibitors with high affinity for the acetylcholinesterase peripheral site.

Cusack B, Romanovskis P, Johnson JL, Etienne G, Rosenberry TL.

Chem Biol Interact. 2005 Dec 15;157-158:370. No abstract available.

PMID:
16429491
31.

Reduction of 13-deoxydoxorubicin and daunorubicinol anthraquinones by human carbonyl reductase.

Slupe A, Williams B, Larson C, Lee LM, Primbs T, Bruesch AJ, Bjorklund C, Warner DL, Peloquin J, Shadle SE, Gambliel HA, Cusack BJ, Olson RD, Charlier HA Jr.

Cardiovasc Toxicol. 2005 Fall;5(4):365-76.

PMID:
16382174
32.

Interactions between the peripheral site and the acylation site in acetylcholinesterase.

Rosenberry TL, Johnson JL, Cusack B, Thomas JL, Emani S, Venkatasubban KS.

Chem Biol Interact. 2005 Dec 15;157-158:181-9. Epub 2005 Oct 27.

PMID:
16256966
33.

Doxorubicin cardiac dysfunction: effects on calcium regulatory proteins, sarcoplasmic reticulum, and triiodothyronine.

Olson RD, Gambliel HA, Vestal RE, Shadle SE, Charlier HA Jr, Cusack BJ.

Cardiovasc Toxicol. 2005;5(3):269-83.

PMID:
16244372
34.

Changes in alternative splicing of human and mouse genes are accompanied by faster evolution of constitutive exons.

Cusack BP, Wolfe KH.

Mol Biol Evol. 2005 Nov;22(11):2198-208. Epub 2005 Jul 27.

PMID:
16049198
35.

Limits on gravitational-wave emission from selected pulsars using LIGO data.

Abbott B, Abbott R, Adhikari R, Ageev A, Allen B, Amin R, Anderson SB, Anderson WG, Araya M, Armandula H, Ashley M, Asiri F, Aufmuth P, Aulbert C, Babak S, Balasubramanian R, Ballmer S, Barish BC, Barker C, Barker D, Barnes M, Barr B, Barton MA, Bayer K, Beausoleil R, Belczynski K, Bennett R, Berukoff SJ, Betzwieser J, Bhawal B, Bilenko IA, Billingsley G, Black E, Blackburn K, Blackburn L, Bland B, Bochner B, Bogue L, Bork R, Bose S, Brady PR, Braginsky VB, Brau JE, Brown DA, Bullington A, Bunkowski A, Buonanno A, Burgess R, Busby D, Butler WE, Byer RL, Cadonati L, Cagnoli G, Camp JB, Cantley CA, Cardenas L, Carter K, Casey MM, Castiglione J, Chandler A, Chapsky J, Charlton P, Chatterji S, Chelkowski S, Chen Y, Chickarmane V, Chin D, Christensen N, Churches D, Cokelaer T, Colacino C, Coldwell R, Coles M, Cook D, Corbitt T, Coyne D, Creighton JD, Creighton TD, Crooks DR, Csatorday P, Cusack BJ, Cutler C, D'Ambrosio E, Danzmann K, Daw E, DeBra D, Delker T, Dergachev V, DeSalvo R, Dhurandhar S, Di Credico A, Díaz M, Ding H, Drever RW, Dupuis RJ, Edlund JA, Ehrens P, Elliffe EJ, Etzel T, Evans M, Evans T, Fairhurst S, Fallnich C, Farnham D, Fejer MM, Findley T, Fine M, Finn LS, Franzen KY, Freise A, Frey R, Fritschel P, Frolov VV, Fyffe M, Ganezer KS, Garofoli J, Giaime JA, Gillespie A, Goda K, González G, Gossler S, Grandclément P, Grant A, Gray C, Gretarsson AM, Grimmett D, Grote H, Grunewald S, Guenther M, Gustafson E, Gustafson R, Hamilton WO, Hammond M, Hanson J, Hardham C, Harms J, Harry G, Hartunian A, Heefner J, Hefetz Y, Heinzel G, Heng IS, Hennessy M, Hepler N, Heptonstall A, Heurs M, Hewitson M, Hild S, Hindman N, Hoang P, Hough J, Hrynevych M, Hua W, Ito M, Itoh Y, Ivanov A, Jennrich O, Johnson B, Johnson WW, Johnston WR, Jones DI, Jones L, Jungwirth D, Kalogera V, Katsavounidis E, Kawabe K, Kawamura S, Kells W, Kern J, Khan A, Killbourn S, Killow CJ, Kim C, King C, King P, Klimenko S, Koranda S, Kötter K, Kovalik J, Kozak D, Krishnan B, Landry M, Langdale J, Lantz B, Lawrence R, Lazzarini A, Lei M, Leonor I, Libbrecht K, Libson A, Lindquist P, Liu S, Logan J, Lormand M, Lubinski M, Lück H, Lyons TT, Machenschalk B, MacInnis M, Mageswaran M, Mailand K, Majid W, Malec M, Mann F, Marin A, Márka S, Maros E, Mason J, Mason K, Matherny O, Matone L, Mavalvala N, McCarthy R, McClelland DE, McHugh M, McNabb JW, Mendell G, Mercer RA, Meshkov S, Messaritaki E, Messenger C, Mitrofanov VP, Mitselmakher G, Mittleman R, Miyakawa O, Miyoki S, Mohanty S, Moreno G, Mossavi K, Mueller G, Mukherjee S, Murray P, Myers J, Nagano S, Nash T, Nayak R, Newton G, Nocera F, Noel JS, Nutzman P, Olson T, O'Reilly B, Ottaway DJ, Ottewill A, Ouimette D, Overmier H, Owen BJ, Pan Y, Papa MA, Parameshwaraiah V, Parameswariah C, Pedraza M, Penn S, Pitkin M, Plissi M, Prix R, Quetschke V, Raab F, Radkins H, Rahkola R, Rakhmanov M, Rao SR, Rawlins K, Ray-Majumder S, Re V, Redding D, Regehr MW, Regimbau T, Reid S, Reilly KT, Reithmaier K, Reitze DH, Richman S, Riesen R, Riles K, Rivera B, Rizzi A, Robertson DI, Robertson NA, Robison L, Roddy S, Rollins J, Romano JD, Romie J, Rong H, Rose D, Rotthoff E, Rowan S, Rüdiger A, Russell P, Ryan K, Salzman I, Sandberg V, Sanders GH, Sannibale V, Sathyaprakash B, Saulson PR, Savage R, Sazonov A, Schilling R, Schlaufman K, Schmidt V, Schnabel R, Schofield R, Schutz BF, Schwinberg P, Scott SM, Seader SE, Searle AC, Sears B, Seel S, Seifert F, Sengupta AS, Shapiro CA, Shawhan P, Shoemaker DH, Shu QZ, Sibley A, Siemens X, Sievers L, Sigg D, Sintes AM, Smith JR, Smith M, Smith MR, Sneddon PH, Spero R, Stapfer G, Steussy D, Strain KA, Strom D, Stuver A, Summerscales T, Sumner MC, Sutton PJ, Sylvestre J, Takamori A, Tanner DB, Tariq H, Taylor I, Taylor R, Taylor R, Thorne KA, Thorne KS, Tibbits M, Tilav S, Tinto M, Tokmakov KV, Torres C, Torrie C, Traylor G, Tyler W, Ugolini D, Ungarelli C, Vallisneri M, van Putten M, Vass S, Vecchio A, Veitch J, Vorvick C, Vyachanin SP, Wallace L, Walther H, Ward H, Ware B, Watts K, Webber D, Weidner A, Weiland U, Weinstein A, Weiss R, Welling H, Wen L, Wen S, Whelan JT, Whitcomb SE, Whiting BF, Wiley S, Wilkinson C, Willems PA, Williams PR, Williams R, Willke B, Wilson A, Winjum BJ, Winkler W, Wise S, Wiseman AG, Woan G, Wooley R, Worden J, Wu W, Yakushin I, Yamamoto H, Yoshida S, Zaleski KD, Zanolin M, Zawischa I, Zhang L, Zhu R, Zotov N, Zucker M, Zweizig J, Kramer M, Lyne AG.

Phys Rev Lett. 2005 May 13;94(18):181103. Epub 2005 May 12.

PMID:
15904354
36.

Pharmacokinetics in older persons.

Cusack BJ.

Am J Geriatr Pharmacother. 2004 Dec;2(4):274-302. Review.

PMID:
15903286
37.

Investigations of calsequestrin as a target for anthracyclines: comparison of functional effects of daunorubicin, daunorubicinol, and trifluoperazine.

Charlier HA Jr, Olson RD, Thornock CM, Mercer WK, Olson DR, Broyles TS, Muhlestein DJ, Larson CL, Cusack BJ, Shadle SE.

Mol Pharmacol. 2005 May;67(5):1505-12. Epub 2005 Feb 10.

PMID:
15705743
38.

Electro-optic modulator capable of generating simultaneous amplitude and phase modulations.

Cusack BJ, Sheard BS, Shaddock DA, Gray MB, Lam PK, Whitcomb SE.

Appl Opt. 2004 Sep 10;43(26):5079-91.

PMID:
15468710
39.

Blood pressure control and factors predicting control in a treatment-compliant male veteran population.

Bizien MD, Jue SG, Panning C, Cusack B, Peterson T.

Pharmacotherapy. 2004 Feb;24(2):179-87.

PMID:
14998218
40.

Inhibitors tethered near the acetylcholinesterase active site serve as molecular rulers of the peripheral and acylation sites.

Johnson JL, Cusack B, Hughes TF, McCullough EH, Fauq A, Romanovskis P, Spatola AF, Rosenberry TL.

J Biol Chem. 2003 Oct 3;278(40):38948-55. Epub 2003 Jul 8.

41.

Unmasking tandem site interaction in human acetylcholinesterase. Substrate activation with a cationic acetanilide substrate.

Johnson JL, Cusack B, Davies MP, Fauq A, Rosenberry TL.

Biochemistry. 2003 May 13;42(18):5438-52.

PMID:
12731886
42.

Anthracycline cardiotoxicity in transgenic mice overexpressing SR Ca2+-ATPase.

Burke BE, Olson RD, Cusack BJ, Gambliel HA, Dillmann WH.

Biochem Biophys Res Commun. 2003 Apr 4;303(2):504-7.

PMID:
12659846
43.

Effect of dexrazoxane on doxorubicin pharmacokinetics in young and old rats.

Cusack BJ, Musser B, Gambliel H, Hadjokas NE, Olson RD.

Cancer Chemother Pharmacol. 2003 Feb;51(2):139-46. Epub 2002 Dec 18.

PMID:
12647015
44.

Synthesis and biological studies of novel neurotensin(8-13) mimetics.

Hong F, Zaidi J, Cusack B, Richelson E.

Bioorg Med Chem. 2002 Dec;10(12):3849-58.

PMID:
12413837
45.

Annotating regulatory DNA based on man-mouse genomic comparison.

Dieterich C, Cusack B, Wang H, Rateitschak K, Krause A, Vingron M.

Bioinformatics. 2002;18 Suppl 2:S84-90.

PMID:
12385988
46.

Effect of aging on cardiac contractility in a rat model of chronic daunorubicin cardiotoxicity.

Cusack BJ, Young SP, Gabliel H, Olson RD.

Cardiovasc Toxicol. 2002;2(2):99-109.

PMID:
12271153
47.

Randomized, controlled trial of phytoestrogen in the prophylactic treatment of menstrual migraine.

Burke BE, Olson RD, Cusack BJ.

Biomed Pharmacother. 2002 Aug;56(6):283-8.

PMID:
12224599
48.

Decreased sensitivity of neonatal rabbit sarcoplasmic reticulum to anthracycline cardiotoxicity.

Burke BE, Mushlin PS, Cusack BJ, Olson SJ, Gambliel HA, Olson RD.

Cardiovasc Toxicol. 2002;2(1):41-51.

PMID:
12189279
49.

Arginine to lysine 108 substitution in recombinant CYP1A2 abolishes methoxyresorufin metabolism in lymphoblastoid cells.

Hadjokas NE, Dai R, Friedman FK, Spence MJ, Cusack BJ, Vestal RE, Ma Y.

Br J Pharmacol. 2002 Jun;136(3):347-52.

50.

Doxorubicin and C-13 deoxydoxorubicin effects on ryanodine receptor gene expression.

Gambliel HA, Burke BE, Cusack BJ, Walsh GM, Zhang YL, Mushlin PS, Olson RD.

Biochem Biophys Res Commun. 2002 Mar 1;291(3):433-8.

PMID:
11855807

Supplemental Content

Loading ...
Support Center